Traduction de «consultation process with various ministers » (Néerlandais → Français) :

My involvement in the consultation process with various Ministers’ offices in preparing the establishment of the FAMHP gave me the opportunity to participate in discussions about the goals of the various committees which were in the process of being created.
My involvement in the consultation process with various Ministers’ offices in preparing the establishment of the FAMHP gave me the opportunity to participate in discussions about the goals of the various committees which were in the process of being created.

BAPCOC (with FPS Public Health) Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Interdepartmental network on “information society services” (with FPS Economy) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI) Working group on blood of the Belgian Federal Supreme Health Council Working group on cells, tissues and organs of the Belgian Federal Supreme Health Council
BAPCOC (with FPS Public Health) Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Interdepartmental network on “information society services” (with FPS Economy) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI) Working group on blood of the Belgian Federal Supreme Health Council Working group on cells, tissues and organs of the Belgian Federal Supreme Health Council

and Public Health Minister’s office “Grey area” consultation platform (with FPS Economie, FPS Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Economie, FPS Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Economie, FPS
and Public Health Minister’s office “Grey area” consultation platform (with FPS Economie, FPS Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Economie, FPS Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Economie, FPS

Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office DGO - SCM guidance committee (with APB and OPHACO) e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees ICVV – CICSA Influenza (in cooperation with external partners) Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Inter DG drugs (with FPS Public Health) Mdeon board of management Potassium iodide tablets campaign (with FPS Interior Affairs) Provincial medical commissions (with FPS Public Health) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI)
Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office DGO - SCM guidance committee (with APB and OPHACO) e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees ICVV – CICSA Influenza (in cooperation with external partners) Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Inter DG drugs (with FPS Public Health) Mdeon board of management Potassium iodide tablets campaign (with FPS Interior Affairs) Provincial medical commissions (with FPS Public Health) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI)

BAPCOC (with FPS Public Health) Board for biosafety (with WIV - ISP and the Biosafety and Biotechnology Service) Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Professional Ethics Committee (with FPS Public Health - DG Animals - Plants - Foodstuffs) Strategic unit/RIZIV - INAMI
BAPCOC (with FPS Public Health) Board for biosafety (with WIV - ISP and the Biosafety and Biotechnology Service) Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Professional Ethics Committee (with FPS Public Health - DG Animals - Plants - Foodstuffs) Strategic unit/RIZIV - INAMI

In order to carry out its various tasks optimally, the FAMHP enlists the help of the FAMHP commissions, the national consultation platforms with other government services, institutions and stakeholders and the FAMHP representatives on national and international commissions, committees and working groups.
In order to carry out its various tasks optimally, the FAMHP enlists the help of the FAMHP commissions, the national consultation platforms with other government services, institutions and stakeholders and the FAMHP representatives on national and international commissions, committees and working groups.

In this context the FAMHP supports provision of pharmacotherapeutic information to care providers and has concluded partnerships with independent organisations providing objective information about medicines (for instance the Belgian Centre for Pharmacotherapeutic Information – BCFI-CBIP and Project Farmaka, not-for-profit organisations). This process needs to take into consideration the expectations of healthcare professionals in terms of information content on the one hand, and the ease of access and consultation of the data on the other.
In this context the FAMHP supports provision of pharmacotherapeutic information to care providers and has concluded partnerships with independent organisations providing objective information about medicines (for instance the Belgian Centre for Pharmacotherapeutic Information – BCFI-CBIP and Project Farmaka, not-for-profit organisations). This process needs to take into consideration the expectations of healthcare professionals in terms of information content on the one hand, and the ease of access and consultation of the data on the other.